The National Institute of Allergy and Infectious Diseases and the National Institute of Environmental Health Sciences cosponsored studies in infant monkeys to compare the tissue distribution, metabolism, and excretion of mercury after exposure to thimerosal and methyl mercury. In this study, one group of animals received a dose of thimerosal in combination with a dose of thimerosal-free infant vaccine by weekly injection beginning at birth and continuing for 3 weeks. The vaccines were included in the study to mimic infant exposure as closely as possible. A second group of animals received methyl mercury orally on a weekly basis beginning at birth and continuing for 3 weeks.
Blood levels of mercury were determined for each animal after each of the four exposures. After the fourth dose, animal tissues were analyzed to determine levels of mercury in target tissues, such as brain and kidney. Assays to determine mercury levels measure inorganic vs. organic mercury but do not distinguish whether the organic mercury is in the form of ethyl mercury from thimerosal or methyl mercury. This study was not designed to measure any type of damage due to mercury exposure.
Results from these studies indicate:
This study shows that , because methyl mercury and thimerosal are distributed and cleared differently in the body, methyl mercury is not a suitable model for risk assessment.
These results were published in Environmental Health Perspectives, Volume 113, Number 8, August 2005
back to top
Last Updated December 09, 2009